re utilized. Nuclear staining was carried out by utilizing 4, 6 diami dino 2 phenylindole. A cell containing additional than ten H2AX foci was consid ered to become positive for damages to DNA. Cell cycle G2M distribution assay Just after the indicated time period, cells had been rinsed with PBS, fixed with 70% ethanol, and incubated overnight at 20 C. Fixed cells had been DBeQ washed and suspended in 500 ul of staining remedy for 30 min. The fluorescence connected with PI bound DNA was measured by flow cytometry. Cell cycle profiles of G2M phase had been cal culated using MultiCycle software. Cell proliferation assays SMMC 7721 and BEL 7402 cells had been plated at 1 x 103 cells per nicely in collagen coated 96 nicely plates. Cell pro liferation assays had been performed by utilizing the Cell Counting Kit eight according to the suppliers protocol.
Briefly, a ten uL of CCK eight remedy was added to every nicely and incu bated at 37 C for 2 h in a humidified CO2 incubator. Optical density was measured at 450 nm using a Microplate Reader plus the proliferation index was calculated because the experi mental OD valuecontrol OD value. Every experiment DBeQ was carried out in quadruplicate and a minimum of 3 occasions independently. Apoptosis assays Just after incubation for 0 h, 24 h, or 48 h just after sorafenib therapy, cells had been harvested, Ferrostatin-1 rinsed, and stained with Annexin V FITC and propidium iodide, as previously described. Statistical analyses Normally distributed continuous variables had been com pared by a single way evaluation of variance. When a considerable distinction involving groups was apparent, various comparisons of implies had been performed using the Dunnett test.
Information are presented as mean normal deviation. All statistical assessments had been two sided and evaluated at the 0. 05 level of considerable differ ence. Statistical analyses had been performed Posttranslational modification using SPSS 15. 0 statistics software. Results Sorafenib modulated radio sensitivity of hepatocellular carcinoma cells in a schedule dependent manner To investigate regardless of whether sorafenib modulated the re sponse of hepatocellular carcinoma cells to radiation, we added sorafenib 30 min prior to or 24 h following irradi ation of hepatocellular carcinoma PluriSln 1 cells SMMC 7721 and BEL 7402 and measured cellular viability by MTT for 6 days. Pre irradiation sorafenib did not sig nificantly influence the viability of SMMC 7221 and BEL 7402 cells. In contrast, post irradiation sorafenib reduced the sensitivity of irra diated SMMC 7221 and BEL 7402 cells drastically in a time dependent manner.
These findings suggested that sorafenib modulated the radio sensitivity of hepatocellular carcinoma cells in a schedule dependent manner in vitro. To additional assess the impact of sorafenib on the radio sensitivity of HCC cell lines, we DBeQ performed clonogenic assays. Radiation triggered a dose dependent cytotoxic ef fect on SMMC 7221 and BEL 7402 cells with significantly less than 20% of cells surviving PluriSln 1 at 4 Gy and significantly less than 0. 1% of cells surviving at ten Gy. The surviving fraction of SMMC 7221 and BEL 7402 cells was 0. 15 0. 05 and 0. 24 0. 02, respectively, at an irradiation dose of 4 Gy. Pre irradiation sorafenib drastically improved the surviving fraction of SMMC 7221 and BEL 7402 cells, for ex ample, sorafenib improved survival of irradiated SMMC 7221 to 0.
21 0. 04 and irradiated BEL 072 to 0. 40 0. 03. These information suggested that sorafenib offered prior to irradiation rendered hepatocellular carcinoma cells additional radio resistant. By contrast, post irradiation sorafe nib added 24 hr post irradiation decreased the surviving fraction of SMMC DBeQ 7221 to 0. 11 0. 01, and that of BEL 7402 cells to 0. 21 0. 03. These information indicated that sorafenib offered 24 h post irradiation improved the radio sensitivity of hepatocellular carcin oma cells. The above findings altogether suggested that sorafenib exerted a schedule dependent impact on the sensitivity of hepatocellular carcinoma cells to radiation.
Pre radiation sorafenib improved potential of irradiated hepatocellular carcinoma cells to subsequently repair DNA harm in vitro Initially, we hypothesized that pre radiation sorafenib improved the sensitivity of irradiated hepatocellular car or truck cinoma cells to the formation of DNA double PluriSln 1 strand breaks. We monitored the formation of DSBs in SMMC 7721 and BEL 7402 cells by examining H2AX induced foci by immunofluorescence. Hepatocellular carcinoma cells had been treated with sorafenib for 30 min prior to radiation. Our immunofluorescence assays showed that 94. 6 3. 5% of irradiated SMMC 7721and 64. 7 2. 9% of irradiated BEL 7402 cells had been positive for H2AX. Similarly, 93. 9 4. 7% and 62. 7 4. 0% of SMMC 7721 and BEL 7402 cells that received each radiation and sorafenib had been positive for H2AX. These information indi cated that pre irradiation sorafenib did not promote radiation induced DSBs. We hypothesized that sorafenib might promote the repair of radiation induced DNA damages. Hence, we compared the percentage of sorafenib treated, irradiated cells for H2AX immunofluorescence to radiation treated cells. At 6 h post irradiation, irradiated SMMC
No comments:
Post a Comment